CBD market have taken off in recent years and are poised for even more explosive success in the years to come. Companies leading the way in the CBD sector, such as Cannonau Corp. (CNNC:US) could be set to profit in the years ahead.
The U.S. hemp-derived CBD market is on target to exceed $5.3 billion in domestic retail sales in 2021, a 15% increase from the $4.6 billion generated through 2020. Consumer interest in CBD products is being driven by increased awareness of the health and wellness boosting potential of cannabis products. Every day more and more consumers are making the connection between achieving better health and wellness outcomes through the use of hemp-derived products.
CBD, also known as cannabidiol, is one of the most explosive health, wellness, and lifestyle products available today. In just 3 short years, this plant-based medicine has become extremely popular due to its potent and evidence-based health and wellness boosting effects. Consumer access is improving all the time but there is still a lot of progress to be made towards achieving full market penetration across all demographic groups that stand to benefit from high-potency CBD products.
According to Single Care, the most common reasons Americans are turning to CBD are pain relief (64%), anxiety (49%), and insomnia (42%). Many consumers are finding real relief using medicinal and over-the-counter, adult-use CBD products. Full-spectrum oils, gummy products, oral sprays, and topical products containing high-potency natural CBD offer health benefits for customers of all ages and many different use-cases.
As these products continue to become more and more mainstream, there are exponential growth opportunities for positioning CBD products in front of people who will gain the most value from them in their daily lives. Increased normalization of cannabis as a potent medicine is creating exciting new treatment options for both patients and medical professionals seeking to offer the highest quality complementary care services.
CNCC is a Uniquely Undervalued American CBD Company
Cannonau Corp. sources all of its CBD from hemp grown on an organic licensed Colorado farm without genetic modification, pesticides, or the use of any other dangerous compounds. The company remains committed to releasing CBD that has been sourced on licensed organic farms using the best practices developed in Colorado, ground zero for the development of America’s true cannabusiness potential.
The company relies on an industry-leading supercritical CO2 extraction method for extracting the phytonutrients from each hemp plant ensuring the oil contains a premium full spectrum of cannabinoids and terpenes. This process guarantees that Cannonau Corp.’s CBD is of the highest quality available and perfect for medicinal use and the creation of consumer consumable products. By choosing the finest Colorado CBD available, the company remains committed to delivering high potency products that have been rigorously vetted to ensure quality and consumer safety.
Guided by an executive leadership team committed to achieving scalable success and a sustainable return on investment for shareholders, Cannonau Corp. has finalized strong partnerships with medical and legal advisory team members Dr. Douglas Pitchford and Mr. Fruqan Mouzon, Esq. The company is poised to position itself for success by unveiling a dynamic domestic and international omnichannel sales strategy that will ensure its ability to capitalize on the tremendous growth of the CBD industry.
The United States has never been more receptive to the potent healing potential of cannabis-derived products such as CBD. Though the main issues that consumers choose CBD products to affect millions of Americans of every age demographic, the usage among those in the Generation X and Baby Boom demographics has been slower. There is tremendous growth potential available as the FDA takes action on the future of CBD in American products in 2022 and consumers become more accustomed to seeing these products available at their favorite stores.
A bipartisan coalition of U.S. representatives recently introduced a bill called the CBD Product Safety and Standardization Act of 2021 which would create a national regulatory framework for the sale and distribution of CBD in food and marketed as a supplement. A move that would drive a sustainable and scalable CBD business environment across North America opening up many new marketing and sales opportunities.
“CBD products are exploding in popularity, but the lack of federal regulation surrounding them has put consumers at risk and left businesses looking for clarity,” Reps. Kathleen Rice (D-N.Y) said. The bill “will establish the clear regulatory framework needed to provide stability for business and ensure unsafe products stay off shelves.”
Cannonau Corp. remains committed to a domestic and international development strategy that will ensure its products are positioned in front of the most lucrative and high-growth consumer demographic groups. The company signed a contract with Virtual Medical International to resell and distribute its products online and in-person in lucrative markets around the world.
The CBD industry is primed to take bold leaps and bounds forward in the coming years and Cannonau Corp. is positioned to capitalize. The CBD industry is taking off and CNCC is the perfect opportunity to invest in an American company driving innovation with a dynamic omnichannel sales strategy, considered executive advisory services, and an eye for the highest quality premium full-spectrum CBD.
How to Start Investing in the CBD Industry
Cannonau Corp (OTC PINK: CNNC) represents a uniquely undervalued opportunity in the United States CBD market that is currently trading well under the $14 price-per-share target set in 2021. Now is the perfect moment to invest in the scalable success and immense future earning potential of the American CBD industry.
Disclaimers: Livestockmarketnews.com is responsible for the production and distribution of this content. Livestockmarketnews.com is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by Livestockmarketnews.com is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall Livestockmarketnews.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by Livestockmarketnews.com, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. Livestockmarketnews.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, Livestockmarketnews.com, its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled
Media Contact
Company Name: https://livestockmarketnews.com
Contact Person: Roger Kelman
Email: info@livestockmarketnews.com
Country: United States
Website: https://www.livestockmarketnews.com
